News

New Coronascape tool will help unlock big-data insights for COVID-19

Bioinformatics platform simplifies data analysis to help biologists glean scientific insights into the novel coronavirus as body of data surges.

$11.4 million NIH grant advances drug to treat nicotine addiction

Funding awarded to scientists at Sanford Burnham Prebys, Camino Pharma and UC San Diego propels drug candidate through first-in-human studies.

Sanford Burnham Prebys receives $3 million NIH award for drugs that restore immune response to COVID-19

Scientists will study how SARS-CoV-19 hijacks the immune system and creates a “cytokine storm”

Scientists uncover a novel approach to treating Duchenne muscular dystrophy

The study reveals a promising new therapeutic approach for the incurable muscle-wasting condition.

Sanford Burnham Prebys awarded $4.5 million NIH grant for mental illness therapeutics

The funding supports the discovery of new classes of drugs that target “orphan” receptors to treat psychological conditions such as schizophrenia, depression, anxiety and substance abuse.